Surein Arulananda is the Deputy Director of Medical Oncology and Thoracic Oncology trials lead at Monash Health. He holds an adjunct associate professor position with Monash University. He completed a PhD in novel therapeutics in mesothelioma and a post-doctoral fellowship at the Dana-Farber Cancer Institute in 2022.  He is Primary Investigator (including Australian lead) on multiple Phase I to III commercial, collaborative and academic studies. He is the associate editor for the Journal of Thoracic Oncology Clinical Research Reports published by the IASLC. He has published over 30 peer-reviewed manuscripts, been an invited speaker both nationally and internationally and has been successful at competitive grant funding. He is the Small Cell Lung Cancer and Mesothelioma Scientific Committee Co-Chair for TOGA and a member of the IASLC Basic and Translational Science Committee.